Our findings are consistent with the previous results reported by Carr et al.17 Moreover, our study is the first one that systematically assessed the association between SLCO1B1 gene T521C polymorphism and statin-related myopathy risk in detail based on a large sample size and different gene contrast models both in the whole population and various subgroups. This evidence concerns the gene SLCO1B1 and myopathy.